Anti-angiogenic cancer therapy based on integrin αvβ3 antagonism
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a
fundamental process during cancer progression. Anti-angiogenic strategies have been …
fundamental process during cancer progression. Anti-angiogenic strategies have been …
Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism
W Cai, X Chen - Anti-cancer agents in medicinal …, 2006 - pubmed.ncbi.nlm.nih.gov
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a
fundamental process during cancer progression. Anti-angiogenic strategies have been …
fundamental process during cancer progression. Anti-angiogenic strategies have been …
Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism
W Cai, X Chen - Anti-Cancer Agents in Medicinal Chemistry, 2006 - cir.nii.ac.jp
抄録< jats: sec>< jats: title/>< jats: p> Angiogenesis, the formation of new blood vessels from
pre-existing vasculature, is a fundamental process during cancer progression. Anti …
pre-existing vasculature, is a fundamental process during cancer progression. Anti …
Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
W Cai, X Chen - Anti-cancer Agents in Medicinal Chemistry, 2006 - europepmc.org
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a
fundamental process during cancer progression. Anti-angiogenic strategies have been …
fundamental process during cancer progression. Anti-angiogenic strategies have been …
[引用][C] Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism
W CAI - Anticancer Agents Med Chem, 2006 - cir.nii.ac.jp